• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice.基于衰弱的心血管疾病管理——从临床试验到临床实践
JAMA Cardiol. 2023 Oct 1;8(10):897-898. doi: 10.1001/jamacardio.2023.1634.
2
Frailty and Cardiovascular Health.虚弱与心血管健康。
J Am Heart Assoc. 2024 Aug 6;13(15):e031736. doi: 10.1161/JAHA.123.031736. Epub 2024 Jul 26.
3
Frailty Syndrome in cardiovascular disease: clinical significance and research tools.心血管疾病中的衰弱综合征：临床意义与研究工具
Eur J Cardiovasc Nurs. 2015 Aug;14(4):303-9. doi: 10.1177/1474515114568059. Epub 2015 Jan 16.
4
Exploring the connection between frailty and cardiovascular diseases.探讨虚弱与心血管疾病之间的联系。
Arch Gerontol Geriatr. 2024 Sep;124:105449. doi: 10.1016/j.archger.2024.105449. Epub 2024 Apr 22.
5
Importance of frailty in patients with cardiovascular disease.衰弱在心血管疾病患者中的重要性。
Eur Heart J. 2014 Jul;35(26):1726-31. doi: 10.1093/eurheartj/ehu197. Epub 2014 May 26.
6
Clinical implication of frailty assessment in older patients with atrial fibrillation.老年房颤患者衰弱评估的临床意义
Arch Gerontol Geriatr. 2017 May-Jun;70:1-7. doi: 10.1016/j.archger.2016.12.001. Epub 2016 Dec 5.
7
Comprehensive Geriatric Assessment in Cardiovascular Disease.心血管疾病中的全面老年评估。
Adv Exp Med Biol. 2020;1216:87-97. doi: 10.1007/978-3-030-33330-0_10.
8
Frailty in cardiovascular disease: Screening tools.心血管疾病中的衰弱：筛查工具
Rev Port Cardiol (Engl Ed). 2019 Feb;38(2):143-158. doi: 10.1016/j.repc.2018.05.019. Epub 2019 Mar 14.
9
Frailty in the cardiac intensive care unit: assessment and impact.心脏重症监护病房的衰弱：评估与影响。
Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):506-514. doi: 10.1093/ehjacc/zuae039.
10
High Prevalence of Geriatric Conditions Among Older Adults With Cardiovascular Disease.老年人心血管疾病患者中老年病的高患病率。
J Am Heart Assoc. 2023 Jan 17;12(2):e026850. doi: 10.1161/JAHA.122.026850. Epub 2023 Jan 11.

引用本文的文献

1
Effect of Frailty on Cardiovascular Clinical Trials: A Systematic Review and Meta-Analysis.衰弱对心血管临床试验的影响：一项系统评价和荟萃分析。
JACC Adv. 2025 Jun 23;4(7):101889. doi: 10.1016/j.jacadv.2025.101889.
2
Assessing Frailty-Specific Treatment Effect in Cardiovascular Disease: A Systematic Review.评估心血管疾病中特定衰弱治疗效果：一项系统评价
Drugs Aging. 2024 Dec;41(12):945-958. doi: 10.1007/s40266-024-01157-2. Epub 2024 Nov 25.
3
Artificial Intelligence (AI)-Driven Frailty Prediction Using Electronic Health Records in Hospitalized Patients With Cardiovascular Disease.利用电子健康记录通过人工智能驱动对心血管疾病住院患者进行衰弱预测
Circ Rep. 2024 Oct 29;6(11):495-504. doi: 10.1253/circrep.CR-24-0112. eCollection 2024 Nov 8.
4
Unleashing frailty from laboratory into real world: A critical step toward frailty-guided clinical care of older adults.从实验室到现实世界释放脆弱性：迈向老年衰弱患者临床护理的关键一步。
J Am Geriatr Soc. 2024 Nov;72(11):3299-3314. doi: 10.1111/jgs.19151. Epub 2024 Aug 21.
5
Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.评估衰弱老年人药物治疗的获益和危害：来自常规医疗保健数据的药物流行病学研究的启示。
Drugs Aging. 2024 Jul;41(7):583-600. doi: 10.1007/s40266-024-01121-0. Epub 2024 Jul 2.
6
Balancing Benefit and Harm of Intensive Blood Pressure Lowering Based on Individual Outcome Profile Analysis.基于个体结局预测分析的强化降压治疗的获益与危害平衡。
Am J Med. 2023 Dec;136(12):1196-1202.e2. doi: 10.1016/j.amjmed.2023.09.003. Epub 2023 Sep 28.

本文引用的文献

1
Frailty Status Modifies the Efficacy of Exercise Training Among Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the HF-ACTION Trial.虚弱状态改变了射血分数降低的慢性心力衰竭患者运动训练的疗效：HF-ACTION 试验的分析。
Circulation. 2022 Jul 12;146(2):80-90. doi: 10.1161/CIRCULATIONAHA.122.059983. Epub 2022 May 26.
2
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.达格列净在射血分数降低的心力衰竭中根据虚弱状况的疗效和安全性：DAPA-HF 试验的事后分析。
Ann Intern Med. 2022 Jun;175(6):820-830. doi: 10.7326/M21-4776. Epub 2022 Apr 26.
3
A scoping review of the Clinical Frailty Scale.临床虚弱量表的范围综述。
BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7.
4
Changes in Predictive Performance of a Frailty Index with Availability of Clinical Domains.临床领域的可用性对衰弱指数预测性能的影响变化。
J Am Geriatr Soc. 2020 Aug;68(8):1771-1777. doi: 10.1111/jgs.16436. Epub 2020 Apr 10.
5
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.强化与标准血压控制对≥75岁成年人心血管疾病结局的影响：一项随机临床试验。
JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.
6
Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.衰弱与非ST段抬高型急性冠状动脉综合征的不良预后相关：来自“旨在明确急性冠状动脉综合征药物治疗最佳策略的靶向血小板抑制（TRILOGY ACS）试验”的见解。
Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):231-42. doi: 10.1177/2048872615581502. Epub 2015 Apr 20.
7
Frailty assessment in the cardiovascular care of older adults.老年人心血管病护理中的衰弱评估。
J Am Coll Cardiol. 2014 Mar 4;63(8):747-62. doi: 10.1016/j.jacc.2013.09.070. Epub 2013 Nov 27.
8
Accumulation of deficits as a proxy measure of aging.将缺陷积累作为衰老的替代指标。
ScientificWorldJournal. 2001 Aug 8;1:323-36. doi: 10.1100/tsw.2001.58.
9
Frailty in older adults: evidence for a phenotype.老年人的衰弱：一种表型的证据。
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56. doi: 10.1093/gerona/56.3.m146.

Frailty-Guided Management of Cardiovascular Disease-From Clinical Trials to Clinical Practice.

作者信息

Kim Dae Hyun, Zhong Lily, Rich Michael W

机构信息

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts.

University of Connecticut School of Medicine, Farmington.

出版信息

JAMA Cardiol. 2023 Oct 1;8(10):897-898. doi: 10.1001/jamacardio.2023.1634.

DOI:10.1001/jamacardio.2023.1634
PMID:37647048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10805234/
Abstract
摘要